Fulcrum Therapeutics, Inc. - Price History
Monthly price history for FULC (Fulcrum Therapeutics, Inc.)
Date | Adjusted price | Real price |
---|---|---|
May 2024 | $7.65 | $7.65 |
April 2024 | $7.13 | $7.13 |
March 2024 | $9.44 | $9.44 |
February 2024 | $10.21 | $10.21 |
January 2024 | $7.22 | $7.22 |
December 2023 | $6.75 | $6.75 |
November 2023 | $4.80 | $4.80 |
October 2023 | $3.64 | $3.64 |
September 2023 | $4.44 | $4.44 |
August 2023 | $5.53 | $5.53 |
July 2023 | $3.82 | $3.82 |
June 2023 | $3.30 | $3.30 |
May 2023 | $2.72 | $2.72 |
April 2023 | $2.50 | $2.50 |
March 2023 | $2.85 | $2.85 |
February 2023 | $6.04 | $6.04 |
January 2023 | $12.61 | $12.61 |
December 2022 | $7.28 | $7.28 |
November 2022 | $6.85 | $6.85 |
October 2022 | $5.56 | $5.56 |
September 2022 | $8.09 | $8.09 |
August 2022 | $7.40 | $7.40 |
July 2022 | $5.88 | $5.88 |
June 2022 | $4.90 | $4.90 |
May 2022 | $7.12 | $7.12 |
April 2022 | $9.62 | $9.62 |
March 2022 | $23.65 | $23.65 |
February 2022 | $11 | $11 |
January 2022 | $12.16 | $12.16 |
December 2021 | $17.69 | $17.69 |
November 2021 | $14.50 | $14.50 |
October 2021 | $22.14 | $22.14 |
September 2021 | $28.21 | $28.21 |
August 2021 | $29.70 | $29.70 |
July 2021 | $7.31 | $7.31 |
June 2021 | $10.48 | $10.48 |
May 2021 | $8.93 | $8.93 |
April 2021 | $11.25 | $11.25 |
March 2021 | $11.78 | $11.78 |
February 2021 | $12.61 | $12.61 |
January 2021 | $11.06 | $11.06 |
December 2020 | $11.71 | $11.71 |
November 2020 | $11.43 | $11.43 |
October 2020 | $9.86 | $9.86 |
September 2020 | $7.93 | $7.93 |
August 2020 | $7.27 | $7.27 |
July 2020 | $15.87 | $15.87 |
June 2020 | $18.29 | $18.29 |
May 2020 | $19.91 | $19.91 |
April 2020 | $12.62 | $12.62 |
March 2020 | $11.94 | $11.94 |
February 2020 | $18.92 | $18.92 |
January 2020 | $17.24 | $17.24 |
December 2019 | $16.64 | $16.64 |
November 2019 | $12.35 | $12.35 |
October 2019 | $6.27 | $6.27 |
September 2019 | $6.64 | $6.64 |
August 2019 | $10.76 | $10.76 |
July 2019 | $13.85 | $13.85 |
FULC
Price: $7.65
52 week price:
Earnings Per Share: -1.59 USD
P/E Ratio: -4.91
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 493900
Market Capitalization: 527.7 million